1. Home
  2. AFBI vs ACTU Comparison

AFBI vs ACTU Comparison

Compare AFBI & ACTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFBI
  • ACTU
  • Stock Information
  • Founded
  • AFBI 1928
  • ACTU 2015
  • Country
  • AFBI United States
  • ACTU United States
  • Employees
  • AFBI N/A
  • ACTU N/A
  • Industry
  • AFBI Major Banks
  • ACTU
  • Sector
  • AFBI Finance
  • ACTU
  • Exchange
  • AFBI Nasdaq
  • ACTU NYSE
  • Market Cap
  • AFBI 140.6M
  • ACTU 153.1M
  • IPO Year
  • AFBI N/A
  • ACTU 2024
  • Fundamental
  • Price
  • AFBI $21.49
  • ACTU $8.68
  • Analyst Decision
  • AFBI
  • ACTU
  • Analyst Count
  • AFBI 0
  • ACTU 0
  • Target Price
  • AFBI N/A
  • ACTU N/A
  • AVG Volume (30 Days)
  • AFBI 6.2K
  • ACTU 57.4K
  • Earning Date
  • AFBI 10-25-2024
  • ACTU 11-13-2024
  • Dividend Yield
  • AFBI N/A
  • ACTU N/A
  • EPS Growth
  • AFBI N/A
  • ACTU N/A
  • EPS
  • AFBI 0.85
  • ACTU N/A
  • Revenue
  • AFBI $30,601,000.00
  • ACTU N/A
  • Revenue This Year
  • AFBI N/A
  • ACTU N/A
  • Revenue Next Year
  • AFBI N/A
  • ACTU N/A
  • P/E Ratio
  • AFBI $25.29
  • ACTU N/A
  • Revenue Growth
  • AFBI 1.34
  • ACTU N/A
  • 52 Week Low
  • AFBI $14.02
  • ACTU $5.51
  • 52 Week High
  • AFBI $22.21
  • ACTU $10.16
  • Technical
  • Relative Strength Index (RSI)
  • AFBI 52.52
  • ACTU N/A
  • Support Level
  • AFBI $21.00
  • ACTU N/A
  • Resistance Level
  • AFBI $22.21
  • ACTU N/A
  • Average True Range (ATR)
  • AFBI 0.36
  • ACTU 0.00
  • MACD
  • AFBI 0.01
  • ACTU 0.00
  • Stochastic Oscillator
  • AFBI 63.27
  • ACTU 0.00

About AFBI Affinity Bancshares Inc. (MD)

Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, and residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

Share on Social Networks: